FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W96465511> ?p ?o ?g. }

• W96465511 endingPage "747" @default.
• W96465511 startingPage "742" @default.
• W96465511 abstract "Docetaxel and carboplatin have shown in vitro and in vivo activity against non-small cell lung cancer (NSCLC). A phase I study was conducted in order to determine the dose-limiting toxicities (DLTs) and the maximum tolerated doses (MTDs) of their combination. Chemotherapy-naïve patients with stage IIIB and IV NSCLC, age<75 years old, performance status (WHO) 0-2, with adequate bone marrow, renal, liver and cardiac function, were treated with docetaxel and carboplatin. Docetaxel was given at escalated doses starting from 70 mg/m(2) with increments of 10 mg/m(2) followed by carboplatin also administered at escalated doses starting from AUC 5 to 7 AUC (mg/ml. min); the regimen was administered every 3 weeks. No colony-stimulating factor or intrapatient escalation was allowed. The toxicity of the regimen was assessed during the first chemotherapy cycle. 35 enrolled patients received a total of 114 chemotherapy cycles (median 3 cycles/patient; range: 1-8). All patients were assessable for toxicity. Neutropenia was the main dose-limiting toxicity of the regimen; overall, grade 3/4 neutropenia occurred in 16 (14%) cycles; six (5%) neutropenic episodes were complicated with fever but there was no septic death. Grade 3/4 thrombocytopenia was uncommon (two cycles; 2%). Grade 3/4 diarrhoea occurred in 5 (14%) patients whilst neurotoxicity, fatigue and mucositis were extremely uncommon. Two MTDs were defined: the MTD(1) was docetaxel 80 mg/m(2) and carboplatin AUC 7 mg/ml x min whilst MTD(2) was docetaxel 100 mg/m(2) and carboplatin AUC 6 mg/ml x min. The combination of docetaxel and carboplatin is a feasible and well-tolerated outpatient regimen for the treatment of patients with locally advanced and metastatic NSCLC. This regimen merits further investigation in phase II trials." @default.
• W96465511 created "2016-06-24" @default.
• W96465511 creator A5000309946 @default.
• W96465511 creator A5001430197 @default.
• W96465511 creator A5006337734 @default.
• W96465511 creator A5007872263 @default.
• W96465511 creator A5021554009 @default.
• W96465511 creator A5027287036 @default.
• W96465511 creator A5037509407 @default.
• W96465511 creator A5045864307 @default.
• W96465511 creator A5065290885 @default.
• W96465511 creator A5076032623 @default.
• W96465511 creator A5076236518 @default.
• W96465511 creator A5084377238 @default.
• W96465511 date "2000-04-01" @default.
• W96465511 modified "2023-09-23" @default.
• W96465511 title "Docetaxel in combination with carboplatin for the treatment of advanced non-small cell lung carcinoma" @default.
• W96465511 cites W1826360242 @default.
• W96465511 cites W1842046266 @default.
• W96465511 cites W1857358013 @default.
• W96465511 cites W1858072261 @default.
• W96465511 cites W1867786113 @default.
• W96465511 cites W1909306097 @default.
• W96465511 cites W1942454844 @default.
• W96465511 cites W1972010711 @default.
• W96465511 cites W1985280527 @default.
• W96465511 cites W2012182477 @default.
• W96465511 cites W2016263166 @default.
• W96465511 cites W2028940434 @default.
• W96465511 cites W2031646868 @default.
• W96465511 cites W2058978290 @default.
• W96465511 cites W2061459572 @default.
• W96465511 cites W2116996913 @default.
• W96465511 cites W2149463127 @default.
• W96465511 cites W2167805334 @default.
• W96465511 cites W2184488763 @default.
• W96465511 cites W2262127979 @default.
• W96465511 cites W4239714259 @default.
• W96465511 cites W4255762755 @default.
• W96465511 doi "https://doi.org/10.1016/s0959-8049(00)00005-8" @default.
• W96465511 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10762746" @default.
• W96465511 hasPublicationYear "2000" @default.
• W96465511 type Work @default.
• W96465511 sameAs 96465511 @default.
• W96465511 citedByCount "12" @default.
• W96465511 crossrefType "journal-article" @default.
• W96465511 hasAuthorship W96465511A5000309946 @default.
• W96465511 hasAuthorship W96465511A5001430197 @default.
• W96465511 hasAuthorship W96465511A5006337734 @default.
• W96465511 hasAuthorship W96465511A5007872263 @default.
• W96465511 hasAuthorship W96465511A5021554009 @default.
• W96465511 hasAuthorship W96465511A5027287036 @default.
• W96465511 hasAuthorship W96465511A5037509407 @default.
• W96465511 hasAuthorship W96465511A5045864307 @default.
• W96465511 hasAuthorship W96465511A5065290885 @default.
• W96465511 hasAuthorship W96465511A5076032623 @default.
• W96465511 hasAuthorship W96465511A5076236518 @default.
• W96465511 hasAuthorship W96465511A5084377238 @default.
• W96465511 hasConcept C126322002 @default.
• W96465511 hasConcept C126894567 @default.
• W96465511 hasConcept C141071460 @default.
• W96465511 hasConcept C143998085 @default.
• W96465511 hasConcept C2776256026 @default.
• W96465511 hasConcept C2776694085 @default.
• W96465511 hasConcept C2777063308 @default.
• W96465511 hasConcept C2778239845 @default.
• W96465511 hasConcept C2778496288 @default.
• W96465511 hasConcept C2778850193 @default.
• W96465511 hasConcept C2781190966 @default.
• W96465511 hasConcept C2781413609 @default.
• W96465511 hasConcept C2781451048 @default.
• W96465511 hasConcept C29730261 @default.
• W96465511 hasConcept C71924100 @default.
• W96465511 hasConcept C90924648 @default.
• W96465511 hasConceptScore W96465511C126322002 @default.
• W96465511 hasConceptScore W96465511C126894567 @default.
• W96465511 hasConceptScore W96465511C141071460 @default.
• W96465511 hasConceptScore W96465511C143998085 @default.
• W96465511 hasConceptScore W96465511C2776256026 @default.
• W96465511 hasConceptScore W96465511C2776694085 @default.
• W96465511 hasConceptScore W96465511C2777063308 @default.
• W96465511 hasConceptScore W96465511C2778239845 @default.
• W96465511 hasConceptScore W96465511C2778496288 @default.
• W96465511 hasConceptScore W96465511C2778850193 @default.
• W96465511 hasConceptScore W96465511C2781190966 @default.
• W96465511 hasConceptScore W96465511C2781413609 @default.
• W96465511 hasConceptScore W96465511C2781451048 @default.
• W96465511 hasConceptScore W96465511C29730261 @default.
• W96465511 hasConceptScore W96465511C71924100 @default.
• W96465511 hasConceptScore W96465511C90924648 @default.
• W96465511 hasIssue "6" @default.
• W96465511 hasLocation W964655111 @default.
• W96465511 hasLocation W964655112 @default.
• W96465511 hasOpenAccess W96465511 @default.
• W96465511 hasPrimaryLocation W964655111 @default.
• W96465511 hasRelatedWork W181704052 @default.
• W96465511 hasRelatedWork W1988518947 @default.
• W96465511 hasRelatedWork W2029433397 @default.

• next